- About us
- A new Institute dedicated to combating Leukemia
- Medical-scientific program
- History of Hematology on the Saint-Louis Campus
- Institute Governance
- Press Room
- Contact us
- Our news
- Profile of Valéria Bisio, Research Officer
- Establishment of a Hemato-Oncogenetics Unit
- Profile of Alice Gros, a peer-support patient
- Laureates of the first call for projects of the Leukemia Institute
- Profile of Julien Calvo, researcher
- Support us
- Join us
- You are
- Patients and relatives
- To be cared for and supported
- Become an expert patient
- Discover the Leukemia Institute
- Researchers
- Research
- Clinical trials
- Discover the Leukemia Institute
- Healthcare professionals
- Refer a patient
- Our clinical research
- Discover the Leukemia Institute
- Industry partners
- Discover the Leukemia Institute
- Translational research
- Donors
- Support us
- Discover the Leukemia Institute
- Care
- Patient care
- Being Treated at the Leukemia Institute
- Anti-cancer Treatments
- Supportive Care
- Open Multidisciplinary Meetings
- Our clinical services
- Department of clinical hematology
- Department of adult hematology
- Hematology Transplant Unit
- Department of Pharmacology and Clinical Investigations
- Department of clinical hematology and cell therapy
- Adolescent and Young Adult Unit
- Outpatient Hemato-oncogenetics Unit
- Department of senior hematology
- Department of pediatric hematology and immunology
- Our medical laboratories
- Hematology Medical Laboratory, Michaela Fontenay
- Hematology Medical Laboratory, Jean Soulier
- Molecular Genetics Unit, Hélène Cavé
- Hematology Medical Laboratory, Vahid Asnafi
- Patient Information
- Acute Myeloid Leukemias
- Acute Lymphoblastic Leukemias
- Myeloproliferative Neoplasms
- Myelodysplastic Syndrome
- Anti-cancer Treatments
- Supportive Care
- Psychological Support
- Research
- Our research teams
- Molecular pathology
- Functional precision medicine for leukemia
- Normal and pathological hematopoiesis
- Niche, Cancer, and Radiation in Hematopoiesis
- Population Evolution and Interaction Particle Systems
- Translational Immunology in Immunotherapy and Hematology (TIGITH)
- Identification and targeting of extrinsic regulators of myeloid malignancies
- Lymphoid niches, Chemokines and Immuno-hematological syndromes
- Molecular Mechanisms of Acute Myeloid Leukemia Development
- Chronic Myeloid Malignancies, Microenvironment & Translational Research
- Leukemia & Niche Dynamics
- Genetic and Epigenetic control of Normal and Malignant Hematopoiesis
- Stem cell dysfunction and secondary AML
- Biostatistics and clinical epidemiology
- Our technological platforms
- Our clinical research
Accueil A new Institute dedicated to combating Leukemia History of Hematology on the Saint-Louis CampusHistory of Hematology on the Saint-Louis Campus
...From 1940 to 1990
1945
First leukemia remission achieved by Professor Jean Bernard and his team at Saint-Louis Hospital.
1980
Professor Jean Dausset awarded the Nobel Prize for the discovery of tissue groups enabling bone marrow transplantation.
1980
International morphological classification of acute leukemias established by George Flandrin and Marie-Thérèse Daniel.
1989
World’s first umbilical cord blood transplant performed by Professor Eliane Gluckman.
From 1990 to 2000
1990
Identification of the PML gene by Professor Hugues de Thé.
1990
Treatment of acute promyelocytic leukemia with retinoic acid by Professors Laurent Degos and Pierre Fenaux.
1990
Development of national cooperative groups for the treatment of acute myeloid and lymphoid leukemias by Professor Hervé Dombret.
1998
Demonstration of the predictive value of minimal residual disease by Professors Hélène Cavé and Bernard Grandchamp.
From 2000 to 2025
2000
Development of molecular hematology at Saint-Louis, Necker, and Robert-Debré Hospitals. Understanding the molecular heterogeneity of leukemias.
2016
First French child with refractory leukemia treated with CAR-T cells at Robert-Debré Hospital by Professor André Baruchel.
2016
Understanding the heterogeneity of genetically driven aplastic anemias.
2019
Establishment of the first national multidisciplinary molecular meetings for acute leukemias.
2020
Innovative treatments for aplastic anemia associated with PNH (paroxysmal nocturnal hemoglobinuria)
2023
Creation of the Leukemia Institute, designated as a University Hospital Institute (IHU) under the France 2030 plan
Leukemia Institute News
ResearchersProfile of Guillaume Andrieu, research officer in the “Normal and Pathological Lymphoid Differentiation” team led by Vahid Asnafi and Elizabeth Macyntire
Read the articlePatientsExceptional launch concert of the Leukemia Institute
Read the articleIndustry partnersSecond edition of LEUKEMIA 360
Read the articleHealthcare professionalsEstablishment of a Hemato-Oncogenetics Unit led by Professor Marie Sébert
Read the articleFrequently Asked Questions
The Saint-Louis Institute, formerly known as the University Institute of Hematology (IUH), takes its name from its historic location at Saint-Louis Hospital in Paris.
Jean Bernard (1907–2006) was a leading figure in French medicine, renowned for his pioneering work in hematology.
He was one of the founders of modern hematology in France.
In 1961, he established the University Institute of Hematology (IUH), which later became the Paris Saint-Louis Leukemia Institute. His goal was to bring together fundamental research, clinical practice, and education.
Jean Dausset (1916–2009) was a French physician, immunologist, and geneticist, internationally renowned for discovering the HLA system (Human Leukocyte Antigens), a major breakthrough in immunology and transplant medicine. He was awarded the Nobel Prize in Medicine in 1980.
Follow our actions by subscribing to the institute's newsletter
- Discover the Leukemia Institute
- Translational research
- Our clinical research
- Clinical trials
- Become an expert patient
- To be cared for and supported
- A new Institute dedicated to combating Leukemia